Lethal effects of physostigmine plus lithium in rats

Area of Science:

• Pharmacology
• Toxicology
• Neuroscience

Background:

• Lithium is a mood stabilizer with a narrow therapeutic index.
• Cholinesterase inhibitors like physostigmine are used in various medical conditions.
• Potential for co-administration of lithium and cholinesterase inhibitors exists in clinical practice.

Purpose of the Study:

• To investigate the interaction between physostigmine and lithium chloride in an animal model.
• To determine the combined toxic effects and potential reversal agents.

Main Methods:

• Adult male rats were administered physostigmine and lithium chloride.
• Lethality rates were compared between individual drug treatments and the combination.
• The effect of scopolamine on the combined toxicity was evaluated.

Main Results:

• The combination of lithium and physostigmine resulted in significantly higher lethality compared to either agent alone.
• Scopolamine administration completely reversed the increased lethality caused by the lithium-physostigmine combination.

Conclusions:

• Physostigmine potentiates the toxicity of lithium, leading to increased mortality in rats.
• Scopolamine acts as an effective antagonist to this drug interaction.
• These findings suggest caution when co-administering lithium and cholinesterase inhibitors due to potential life-threatening interactions.